CD8A and neoplasm: TAA-specific Tregs were successfully identified using a p53 peptide [105]; in addition to CD4+ Tregs also CD8+CD28− Tregs could be isolated from peripheral blood, tumor tissue, and metastatic lymph nodes of CRC patients [106].